drugset / Trial / NCT06729463

IKBKB Gene Polymorphism (Single Nucleotide Polymorphism) (SNP) in Psoriatic and Psoriatic Arthritis Patients

NCT06729463

Completed 50 enrolled South Valley University
RandomizedParallel-groupOpen-labelTreatment

Summary

Psoriasis is a chronic inflammatory skin disease characterized by scaly indurated erythema. It impairs patients' quality of life enormously. Psoriasis refers to a persistent inflammatory illness of the skin and joints. It also impacts roughly 2%-3% of the inhabitants of the universe

Timeline

Start
2024-12-01
Primary completion
2025-03-01
Completion
2025-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adalimumab Monoclonal antibody 40 mg Subcutaneous
Comparator Secukinumab Monoclonal antibody 150 mg Intravenous